Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection (CROSBI ID 117451)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Babić, Žarko ; Svoboda-Beusan, Ivna ; Kučišec-Tepeš, Nastja ; Dekaris, Dragan ; Troskot, Rosana Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection // World journal of gastroenterology, 11 (2005), 18; 2720-2725. doi: 10.3748/wjg.v11.i18.2720

Podaci o odgovornosti

Babić, Žarko ; Svoboda-Beusan, Ivna ; Kučišec-Tepeš, Nastja ; Dekaris, Dragan ; Troskot, Rosana

engleski

Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection

To determine whether local antibiotic resistance involves P-glycoprotein (Pgp)-mediated active drug outpumping during Helicobacter pylori (H pylori) infection treatment with classic antibiotic therapy. Pgp activity was determined in gastric mucosa biopsy specimens obtained from 53 patients with pathohistologically verified gastritis and microbiologically confirmed H pylori infection, and compared with the Pgp activity in 12 control subjects with normal endoscopic findings. The H pylori positive patients were treated with short-term 7-d therapy consisting of two antibiotics (amoxicillin and azithromycin/metronidazole and clarithromycin) and a proton pump inhibitor. Pgp activity was determined by flow cytometry in the test of rhodamine dye efflux and quantified as mean fluorescence ratio (RMF). Upon the first cycle, H pylori was successfully eradicated in 20 patients, whereas therapy was continued in 33 patients. In the course of antibiotic therapy, RMF increased (P<0.05) and gastric cells showed higher rhodamine dye efflux. The mean pre-treatment RMF values were also higher (P<0.0001) in patients with multiple therapeutic failure than in those with successful H pylori eradication and control subjects. Pgp might be one of the causes of therapy failure in patients with H pylori and antibiotic therapy could be chosen and followed up on the basis of the Pgp transporter local activity.

H pylori ; RMF ; Pgp

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

11 (18)

2005.

2720-2725

objavljeno

1007-9327

2219-2840

10.3748/wjg.v11.i18.2720

Povezanost rada

Kliničke medicinske znanosti, Temeljne medicinske znanosti

Poveznice
Indeksiranost